
Insiders are buying healthcare companies in 2025, with a notable increase in Q3.
The stocks on this list provide a value, often a deep value, relative to prior action; the question is whether they are a good buy for investors.

Insiders are buying healthcare companies in 2025, with a notable increase in Q3.
The stocks on this list provide a value, often a deep value, relative to prior action; the question is whether they are a good buy for investors.